Silicon Laboratories (NASDAQ:SLAB) Stock Rating Upgraded by StockNews.com

Silicon Laboratories (NASDAQ:SLAB) was upgraded by analysts at StockNews.com to a “sell” rating in a report issued on Friday.

Several other equities analysts have also commented on the company. Morgan Stanley reduced their price objective on Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Barclays reduced their price target on Silicon Laboratories from $120.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Tuesday. JPMorgan Chase & Co. reduced their price target on Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating on the stock in a research report on Tuesday. Stifel Nicolaus reduced their price target on Silicon Laboratories from $160.00 to $135.00 and set a “buy” rating on the stock in a research report on Tuesday. Finally, KeyCorp cut their price objective on Silicon Laboratories from $150.00 to $115.00 and set an “overweight” rating on the stock in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $121.50.

Silicon Laboratories Price Performance

NASDAQ SLAB opened at $113.65 on Friday. Silicon Laboratories has a one year low of $92.55 and a one year high of $154.91. The business has a 50 day simple moving average of $112.22 and a 200 day simple moving average of $115.47. The stock has a market capitalization of $3.67 billion, a P/E ratio of -15.36 and a beta of 1.20.

Silicon Laboratories (NASDAQ:SLAB) last issued its quarterly earnings results on Monday, November 4th. The semiconductor company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.07. The business had revenue of $166.00 million for the quarter, compared to analyst estimates of $165.50 million. Silicon Laboratories had a negative return on equity of 12.40% and a negative net margin of 46.93%. Silicon Laboratories’s quarterly revenue was down 18.5% compared to the same quarter last year. During the same period last year, the company posted $0.48 earnings per share. Equities analysts expect that Silicon Laboratories will post -3.41 earnings per share for the current year.

Insider Buying and Selling

In related news, SVP Brandon Tolany sold 845 shares of Silicon Laboratories stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $115.00, for a total value of $97,175.00. Following the completion of the sale, the senior vice president now owns 43,615 shares of the company’s stock, valued at $5,015,725. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.72% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Silicon Laboratories

Institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in Silicon Laboratories by 0.7% during the 1st quarter. Vanguard Group Inc. now owns 3,489,160 shares of the semiconductor company’s stock worth $501,462,000 after purchasing an additional 24,997 shares during the period. Capital Research Global Investors increased its holdings in shares of Silicon Laboratories by 29.9% in the 1st quarter. Capital Research Global Investors now owns 1,217,939 shares of the semiconductor company’s stock valued at $175,042,000 after acquiring an additional 280,000 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Silicon Laboratories by 2.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 639,065 shares of the semiconductor company’s stock valued at $70,699,000 after acquiring an additional 12,680 shares during the period. Van Berkom & Associates Inc. increased its holdings in shares of Silicon Laboratories by 8.4% in the 2nd quarter. Van Berkom & Associates Inc. now owns 609,232 shares of the semiconductor company’s stock valued at $67,399,000 after acquiring an additional 47,058 shares during the period. Finally, Federated Hermes Inc. increased its holdings in shares of Silicon Laboratories by 2.2% in the 2nd quarter. Federated Hermes Inc. now owns 545,833 shares of the semiconductor company’s stock valued at $60,386,000 after acquiring an additional 11,981 shares during the period.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.